<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01559350</url>
  </required_header>
  <id_info>
    <org_study_id>2011-11-065</org_study_id>
    <nct_id>NCT01559350</nct_id>
  </id_info>
  <brief_title>Graft Patency Analysis of the Right Coronary Artery System</brief_title>
  <official_title>Graft Patency of the Right Coronary Artery System in OPCAB: Saphenous Vein Graft Versus Right Gastroepiploic Artery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ideal grafts for the right coronary artery system in coronary artery bypass surgery
      remain controversial. The objective of this study is to compare the long-term patency of a
      right gastroepiploic artery and a saphenous vein graft used for revascularization of the
      right coronary artery system in off pump coronary artery bypass surgery and to analyze the
      long-term clinical outcomes.

      Total 224 patients will be enrolled according to the randomization protocol.

      Check list

        1. Laboratories

        2. Quantitative coronary analysis (preoperative)

        3. Major adverse cardiac and cerebrovascular event

        4. coronary CT (coronary angiography if needed) at discharge, 1, 5, 10 years
           postoperatively

        5. Echocardiogram

      5. Cardiac enzyme
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ideal bypass conduit for the right coronary artery remains a subject of intense
      controversy. A variety of grafts and configurations are used: the right gastroepiploic
      artery,the right internal thoracic artery in situ or in a Y-graft configuration,the free
      radial artery implanted into the aorta or the left internal thoracic artery, and the
      saphenous vein graft. The influence of the type of graft to the right coronary artery system
      on clinical results remains poorly documented, and the complementary conduit of choice to
      this system has yet to be determined. No superior long-term patency rate for any of these
      grafts to the RCA has been clearly established. We have used a saphenous vein and a right
      gastroepiploic artery for the right coronary artery system.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor recruiting rate
  </why_stopped>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Graft occlusion</measure>
    <time_frame>one year</time_frame>
    <description>Coronary CT follow up at discharge, 1, 5 and 10 years postoperatively</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>RGEA group</arm_group_label>
    <description>A right gastroepiploic artery in situ grafting in the right coronary artery system during OPCAB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SVG group</arm_group_label>
    <description>A saphenous vein grafting in the right coronary artery system during OPCAB</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>A right gastroepiploic artery in situ grafting</intervention_name>
    <description>A right gastroepiploic artery in situ grafting in the right coronary artery system during OPCAB</description>
    <arm_group_label>RGEA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>A saphenous vein grafting</intervention_name>
    <description>A saphenous vein grafting in the right coronary artery system during OPCAB</description>
    <arm_group_label>SVG group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who undergo OPCAB for triple vessel disease at Samsung Medical Center are
        enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Angiographic evidence of severe coronary stenosis on the right coronary territory

          -  Elective surgery

          -  Isolated off pump CABG

          -  Age &lt; 75 years and life expectancy &gt; 5 years

          -  Preoperative RGEA diameter &gt; 1.5mm

          -  Normal left ventricular function

        Exclusion Criteria:

          -  History of upper abdomen surgery

          -  History of upper GI bleeding

          -  Active gastric or duodenal ulcer

          -  Body mass index &gt; 35kg/m2

          -  Redo surgery

          -  Presence of varicose vein

          -  Contraindication for CABG such as malignancy or liver cirrhosis

          -  Other configuration than RGEA to RCA territory or SVG to RCA territory
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young Tak Lee, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2012</study_first_submitted>
  <study_first_submitted_qc>March 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2012</study_first_posted>
  <last_update_submitted>April 13, 2016</last_update_submitted>
  <last_update_submitted_qc>April 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OPCAB</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

